PhotoCure ASA

PHO

Company Profile

  • Business description

    PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.

  • Contact

    Hoffsveien 4
    Oslo0275
    NOR

    T: +47 22062210

    E: [email protected]

    https://www.photocure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    101

Stocks News & Analysis

stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.
stocks

Undervalued ASX share searches for cost savings

Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks

Chart of the Week: Where we see opportunities after year end market sell-off

The latest insights from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,983.3028.900.32%
CAC 408,068.6217.14-0.21%
DAX 4024,186.49108.12-0.45%
Dow JONES (US)48,458.05245.96-0.51%
FTSE 1009,649.0354.13-0.56%
HKSE25,976.79446.281.75%
NASDAQ23,195.17398.69-1.69%
Nikkei 22550,836.55687.731.37%
NZX 50 Index13,406.9111.040.08%
S&P 5006,827.4173.59-1.07%
S&P/ASX 2008,697.3032.400.37%
SSE Composite Index3,889.3516.030.41%

Market Movers